Tang et al recently reported that, in COVID-19 infections caused by the novel coronavirus
(SARS-CoV-2), heparin anticoagulant therapy lowers the mortality rate in patients who …

Dear Editor, We read with interest the study published by Tang et al1 in a recent issue of the
Journal of Thrombosis and Haemostasis. In this retrospective analysis, conducted at the …

SARS-Cov-2 induces in severe cases a cytokine storm that ultimately leads to the activation
of coagulation cascade, causing thrombotic phenomena. 5 There is a further strong link …

Coagulopathy in coronavirus infection has been shown to be associated with high mortality
with high D-dimers being a particularly important marker for the coagulopathy. 1 In the latest …

A recently published article by Dr. Tang and colleagues on “Abnormal coagulation
parameters are associated with poor prognosis in patients with novel coronavirus …

The unrelenting acceleration of COVID-19 infections due to SARS-CoV-2 is unquestionably
the greatest medical challenge of our professional careers. The Scientific and …

Coronavirus disease 2019 (COVID-19) is a new, emerging medical challenge worldwide,
with those affected showing a variety of clinical presentations, ranging from asymptomatic or …

Mounting evidence supports the strong prognostic importance of D-dimers and the impact of
coagulopathy in COVID-19 patients [1, 2, 3]. We would like to emphasize the significance of …

Severe acute respiratory syndrome coronavirus 2, coronavirus disease 2019 (COVID-19)-
induced infection can be associated with a coagulopathy, findings consistent with infection …

United States alone. SARS-CoV-2 enters cells by binding to the angiotensinconverting
enzyme 2 receptor, which is expressed on respiratory epithelial cells and other cell types …